Home > News > NanoViricides, Inc. Presents at FDA Nanotechnology Meeting
October 11th, 2006
NanoViricides, Inc. Presents at FDA Nanotechnology Meeting
Abstract:
NanoViricides, Inc, (Pink Sheets: NNVC) President and Chairman, Dr. Anil Diwan, presented a talk at the U.S. Food and Drug Administration (FDA) Public Meeting on Nanotechnology in Bethesda, MD on Oct. 10. “Such high drug efficacies as shown by nanoviricides drugs compared to existing therapies may very well represent a new plateau in anti-viral therapy,” he said.
Source:
businesswire
Related News Press |
Preparing for Nano
Disruptive by Design: Nano Now February 1st, 2019
How nanoscience will improve our health and lives in the coming years: Targeted medicine deliveries and increased energy efficiency are just two of many ways October 26th, 2016
Searching for a nanotech self-organizing principle May 1st, 2016
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||